Aktie 4952 SDS BIOTECH K.K.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen SDS Biotech K.K.

Aktien

4952

JP3163200003

4952

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Idemitsu Kosan Co.,Ltd. completed the acquisition of remaining 30.3% stake in SDS Biotech K.K. from group of sellers.
Idemitsu Kosan Co.,Ltd. entered into Share Exchange Agreement to acquire remaining 30.3% stake in SDS Biotech K.K. from group of sellers for ¥3.1 billion.
SDS Biotech K.K. Reports Earnings Results for the Second Quarter of 2021
SDS Biotech K.K. Announces Consolidated Financial Results for the Nine Months Ended December 31, 2019; Provides Consolidated Financial Guidance for the Year Ending March 31, 2020
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Full Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter of Fiscal Year 2020 and Full Year Ending March 31, 2020
Sds Biotech K.K. Announces Consolidated Earnings Results for the Year Ended March 31, 2018
R.Narasimhan, R.Padmanaban, R.Gopal completed the acquisition of an additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K..
SDS Ramcides Cropscience Private Limited announced that it expects to receive INR 1.32 billion in funding from SDS Biotech K.K.
R.Narasimhan, R.Padmanaban, R.Gopal entered into an agreement to acquire additional 97.95% stake in SDS Ramcides Cropscience Private Limited from SDS Biotech K.K. for INR 0.21 million.
SDS Biotech K.K. Announces Consolidated Earnings Results for the Third Quarter Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Year Ending March 31, 2018
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018
SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2018
SDS Biotech K.K. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2017; Announces Dividend for the Year Ended March 31, 2017, Payable on June 29, 2017; Provides Earnings Guidance for the Year Ending March 31, 2018; Provides Dividend Guidance for the Second Quarter and Fiscal Year 2018
SDS Biotech K.K. Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2016; Revised Consolidated Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017
SDS Biotech K.K. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017
SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017
SDS Biotech K.K. Reports Consolidated Earnings Results for the Period Ended December 31, 2015; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2016; Provides Dividend Guidance for the Full Year Ending March 31, 2016
SDS Biotech K.K. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Year Ended March 31, 2016; Announces Change in Fiscal Year from December 31 to March 31
SDS Biotech K.K. Reports Consolidated Earnings Results for the Second Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance and Dividend Guidance for the Fiscal Year Ending March 2016
SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2016
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4952 Aktie
  4. Nachrichten SDS Biotech K.K.
  5. Andere Sprachen